CClinicalTrials.gg
CompletedNCT04749316Updated Feb 11, 2021

Acs-Tens Treatment for Faecal Incontinence: a RCT With Sham-controls

An interventional study of AcuTENS in Faecal Incontinence, Faecal Incontinence With Faecal Urgency and Neuromodulation, sponsored by Chinese University of Hong Kong. Completed at 1 site in Hong Kong. Open to participants aged 18 Years to 99 Years. Per ClinicalTrials.gov, last updated 2021-02-11.

Sponsored by Chinese University of Hong Kong · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 years 6 months after the study started (first participant enrolled Aug 2017, registered Feb 2021).
Phase
Not applicable
Study type
Interventional
Enrollment
53
Allocation
Randomized
Ages
18 Years to 99 Years
Sex
All
01

Study summary

This study assess the effectiveness on AcuTENS on the treatment of faecal incontinence

Read the detailed description

Faecal incontinence (FI) is the involuntary loss of flatus, liquid or solid stool per rectum. Owing to the emotional stress and the psychosocial stigma surrounding this problem, it is under-reported by patients.

Conservative management of FI involves lifestyle, medical adjustments and pelvic floor sphincter training. If conservative treatment fails, surgical options such as sphincter repair, sacral nerve stimulation (SNM) and percutaneous tibial nerve stimulation (PTNS) can be reformed. SNM and PTNS involve application of nervous electrical stimulation (neuromodulation) with significant improvement of symptoms. The positions of electrical stimuli are also very similar to acupuncture sites (acupoints) used in Traditional Chinese Medicine for the treatment of faecal incontinence. However, disadvantage of these methods are; 1) they are invasive and may cause complications such as pain, infection and bleeding and; 2) the devices for each SNM device can be costly.

Transcutaneous Electrical Nerve Stimulation (TENS) is non-invasive, which is commonly used for the management of pain. It works via the application of electrical stimuli using adhesive gel pads. They are cheap to run and are widely accepted by patients. Hence application of TENS over acupoints (Acu-TENS) may provide a novel non-invasive treatment.

A randomised controlled trial will be carried out on patients with FI. Demographic data, past medical history, in particular any structural or neurological causes of FI, will be recorded. Ano-rectal manometry and endoanal ultrasound will be performed before and after treatment. Acu-TENS machine will be applied to standardised acupuncture points. Assessment of FI via Cleveland Clinic Florida Faecal Incontinence Score and Quality of life measurements via the validated questionnaires Short Form 36 (SF-36) and the Fecal Incontinence Quality of Life Scale (FIQL) (Chinese version) questionnaires will be carried out at baseline, and followup intervals.

02

Conditions studied

  • Faecal Incontinence
  • Faecal Incontinence With Faecal Urgency
  • Neuromodulation
  • Transcutaneous Electric Nerve Stimulation
  • Acupuncture Points

Browse trials for

Keywords

  • Faecal incontinence
  • Faecal urgency
  • Neuromodulation
  • Transcutaneous Electric Nerve Stimulation
  • Acupuncture
03

In context

Fecal Incontinence

312 studies on the registry are indexed under Fecal Incontinence; 57 are open to participants now.

This study's enrollment of 53 is close to the median of 50 across 216 interventional studies indexed under Fecal Incontinence.

Browse Fecal Incontinence studies →

Lead sponsor

Chinese University of Hong Kong is the lead sponsor of 1,419 studies on the registry; 487 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients aged 18 years or above
  • Acupuncture naïve patients
  • Faecal incontinence with solid or liquid stool causing disruption of lifestyle
  • Psychological stability and suitability as determined by the investigator
  • Failed conservative or surgical treatment
  • Intact peripheral neurosensory nervous system as determined by clinical investigation
  • Able to read and write

Exclusion criteria

Exclusion Criteria:

  • Major internal and/or external sphincter defect (>120 degrees of sphincter circumference)
  • Faecal impaction
  • Presence of full thickness rectal prolapse
  • Patients who have contact allergies to adhesive pads
  • Implanted pacemaker, defibrillator, cardiopathy
  • Pregnancy or intention to become pregnant
  • Neurogenic or congenital disorders resulting in faecal incontinence (e.g. Multiple Sclerosis, uncontrolled diabetes, Parkinson's disease, Spina Bifida)
  • Inflammatory bowel disease
  • Chronic diarrhoea uncontrolled by medication or diet
  • Previous rectal surgery (rectopexy or rectal resection)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
53 participants (actual)

Study arms

  • Experimental
    AcuTENS

    Patients treated with TENS over Acupuncture points for faecal incontinence

    Procedure: AcuTENS

  • Sham comparator
    Sham

    Sham treatment arm with no electrical stimulations over acupuncture points

    Procedure: AcuTENS

Interventions

  • ProcedureAcuTENS

    Stimulation of acupuncture points with TENS machine

06

What researchers measure

Primary outcomes

  1. Effectiveness of AcuTENS as treatment for faecal incontinence compared with sham intervention

    Response to treatment is defined as 50% or greater change in Faecal incontinence Severity index score compared to sham

    Time frame: post treatment 8 weeks and 6 months compared with baseline

Secondary outcomes

  1. Changes in the severity of faecal incontience

    Wexner score will be used the assess the severity of faecal incontinence

    Time frame: post treatment 8 weeks and 6 months compared with baseline

  2. Episodes of faecal urgency per week

    the number of episodes of faecal urgency experienced by the patient per week

    Time frame: post treatment 8 weeks and 6 months compared with baseline

  3. Reduction in the number of incontinence episode per week

    the number of episodes of faecal incontience experienced by the patient per week

    Time frame: post treatment 8 weeks and 6 months compared with baseline

  4. Differences in Quality of Life score between two groups

    using the tradition chinese version of the faecal incontinence quality of life questionnaire (FIQL)

    Time frame: post treatment 8 weeks and 6 months compared with baseline

07

Study locations

1 site
  • Chinese University of Hong Kong
    Sha Tin, Hong Kong
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 11, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04749316
Lead sponsor
Chinese University of Hong Kong
Collaborators
Health and Medical Research Fund
Responsible party
Tony Wing Chung Mak (Associate Professor, Chinese University of Hong Kong) — Principal investigator
First posted
Feb 11, 2021
Start date
Aug 1, 2017
Primary completion
Oct 30, 2020
Completion
Dec 31, 2020
Last update
Feb 11, 2021

Study contacts

Tony WC Mak, MD, FRCS
principal investigator · Chinese University of Hong Kong

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion